Back to today’s briefing

Story perspectives

NIH and FDA Forge Divergent Paths in AI Healthcare

6/12/2025

30 4

Summary

NIH and FDA Innovate AI

The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are charting distinct paths in the realm of artificial intelligence in healthcare. While the NIH champions collaborative research to push AI advancements, the FDA is crafting regulatory frameworks to guarantee the safety and effectiveness of AI-powered medical devices. Together, they acknowledge AI's revolutionary promise for the future of medicine.

Summary

FDA Revamps Approvals

The FDA is set to revolutionize drug approvals with artificial intelligence, cutting down lengthy processes that can span months or even years. Spearheaded by Dr. Marty Makary and Dr. Vinay Prasad, this initiative not only aims for efficiency but also prioritizes healthier food choices for children, striving to rebuild public confidence in the agency's decisions.

1 of 2

NIH and FDA Innovate AI

The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are charting distinct paths in the realm of artificial intelligence in healthcare. While the NIH champions collaborative research to push AI advancements, the FDA is crafting regulatory frameworks to guarantee the safety and effectiveness of AI-powered medical devices. Together, they acknowledge AI's revolutionary promise for the future of medicine.

1 / 2